147 related articles for article (PubMed ID: 23714244)
1. Post-translational regulation of a hypoxia-responsive VEGF plasmid for the treatment of myocardial ischemia.
Won YW; McGinn AN; Lee M; Nam K; Bull DA; Kim SW
Biomaterials; 2013 Aug; 34(26):6229-38. PubMed ID: 23714244
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible vascular endothelial growth factor gene therapy using the oxygen-dependent degradation domain in myocardial ischemia.
Kim HA; Lim S; Moon HH; Kim SW; Hwang KC; Lee M; Kim SH; Choi D
Pharm Res; 2010 Oct; 27(10):2075-84. PubMed ID: 20607367
[TBL] [Abstract][Full Text] [Related]
3. Post-translational regulated and hypoxia-responsible VEGF plasmid for efficient secretion.
Won YW; Lee M; Kim HA; Bull DA; Kim SW
J Control Release; 2012 Jun; 160(3):525-31. PubMed ID: 22450332
[TBL] [Abstract][Full Text] [Related]
4. Reducible poly(amido ethylenediamine) for hypoxia-inducible VEGF delivery.
Christensen LV; Chang CW; Yockman JW; Conners R; Jackson H; Zhong Z; Feijen J; Bull DA; Kim SW
J Control Release; 2007 Apr; 118(2):254-61. PubMed ID: 17276536
[TBL] [Abstract][Full Text] [Related]
5. VEGF therapeutic gene delivery using dendrimer type bio-reducible polymer into human mesenchymal stem cells (hMSCs).
Kim H; Nam K; Nam JP; Kim HS; Kim YM; Joo WS; Kim SW
J Control Release; 2015 Dec; 220(Pt A):222-228. PubMed ID: 26368313
[TBL] [Abstract][Full Text] [Related]
6. Dendrimer type bio-reducible polymer for efficient gene delivery.
Nam HY; Nam K; Lee M; Kim SW; Bull DA
J Control Release; 2012 Jun; 160(3):592-600. PubMed ID: 22546681
[TBL] [Abstract][Full Text] [Related]
7. Tumor targeting RGD conjugated bio-reducible polymer for VEGF siRNA expressing plasmid delivery.
Kim HA; Nam K; Kim SW
Biomaterials; 2014 Aug; 35(26):7543-52. PubMed ID: 24894645
[TBL] [Abstract][Full Text] [Related]
8. Hypoxic response elements control expression of human vascular endothelial growth factor(165) genes transferred to ischemia myocardium in vivo and in vitro.
Jiang B; Dong H; Zhang Z; Wang W; Zhang Y; Xu X
J Gene Med; 2007 Sep; 9(9):788-96. PubMed ID: 17610292
[TBL] [Abstract][Full Text] [Related]
9. Adeno-associated viral vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts.
Su H; Joho S; Huang Y; Barcena A; Arakawa-Hoyt J; Grossman W; Kan YW
Proc Natl Acad Sci U S A; 2004 Nov; 101(46):16280-5. PubMed ID: 15534198
[TBL] [Abstract][Full Text] [Related]
10. Polymeric gene delivery of ischemia-inducible VEGF significantly attenuates infarct size and apoptosis following myocardial infarct.
Yockman JW; Choi D; Whitten MG; Chang CW; Kastenmeier A; Erickson H; Albanil A; Lee M; Kim SW; Bull DA
Gene Ther; 2009 Jan; 16(1):127-35. PubMed ID: 18784748
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of dendrimer type bio-reducible polymer as a siRNA delivery carrier for cancer therapy.
Nam JP; Nam K; Jung S; Nah JW; Kim SW
J Control Release; 2015 Jul; 209():179-85. PubMed ID: 25937533
[TBL] [Abstract][Full Text] [Related]
12. Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction.
Yockman JW; Kastenmeier A; Erickson HM; Brumbach JG; Whitten MG; Albanil A; Li DY; Kim SW; Bull DA
J Control Release; 2008 Dec; 132(3):260-6. PubMed ID: 18662730
[TBL] [Abstract][Full Text] [Related]
13. Efficient GLP-1 gene delivery using two-step transcription amplification plasmid system with a secretion signal peptide and arginine-grafted bioreducible polymer.
Kim TI; Lee M; Kim SW
J Control Release; 2012 Jan; 157(2):243-8. PubMed ID: 21945681
[TBL] [Abstract][Full Text] [Related]
14. Targeted gene delivery to ischemic myocardium by homing peptide-guided polymeric carrier.
Won YW; McGinn AN; Lee M; Bull DA; Kim SW
Mol Pharm; 2013 Jan; 10(1):378-85. PubMed ID: 23214982
[TBL] [Abstract][Full Text] [Related]
15. Role of the oxygen-dependent degradation domain in a hypoxia-inducible gene expression system in vascular endothelial growth factor gene therapy.
Jin H; Liu ML; Kim HA; Lee M; An S; Oh J; Cho J; Yi S; Kim K; Yoon D; Ha Y
Spine (Phila Pa 1976); 2009 Dec; 34(26):E952-8. PubMed ID: 20010384
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous regulation of apoptotic gene silencing and angiogenic gene expression for myocardial infarction therapy: Single-carrier delivery of SHP-1 siRNA and VEGF-expressing pDNA.
Kim D; Ku SH; Kim H; Jeong JH; Lee M; Kwon IC; Choi D; Kim SH
J Control Release; 2016 Dec; 243():182-194. PubMed ID: 27765623
[TBL] [Abstract][Full Text] [Related]
17. Angiogenic and pleiotropic effects of VEGF165 and HGF combined gene therapy in a rat model of myocardial infarction.
Makarevich PI; Dergilev KV; Tsokolaeva ZI; Boldyreva MA; Shevchenko EK; Gluhanyuk EV; Gallinger JO; Menshikov MY; Parfyonova YV
PLoS One; 2018; 13(5):e0197566. PubMed ID: 29787588
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible expression of vascular endothelial growth factor for the treatment of spinal cord injury in a rat model.
Choi UH; Ha Y; Huang X; Park SR; Chung J; Hyun DK; Park H; Park HC; Kim SW; Lee M
J Neurosurg Spine; 2007 Jul; 7(1):54-60. PubMed ID: 17633488
[TBL] [Abstract][Full Text] [Related]
19. Delivery of two-step transcription amplification exendin-4 plasmid system with arginine-grafted bioreducible polymer in type 2 diabetes animal model.
Kim PH; Lee M; Kim SW
J Control Release; 2012 Aug; 162(1):9-18. PubMed ID: 22705459
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in a rat model following myocardial infarction induced by hypoxic regulation of VEGF₁₆₅ gene-transfected EPCs.
She Q; Xia S; Deng SB; Du JL; Li YQ; He L; Xiao J; Xiang YL
Mol Med Rep; 2012 Dec; 6(6):1281-7. PubMed ID: 23027149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
